News and press releases

Cabinet comes to the rescue with the restart of the Apotex pharma factory

Screenshot of the fd Website News article on InnoGenerics

Closure of the company’s factory in Leiden has been prevented, partly due to a loan from the cabinet.

The Apotex drug factory in Leiden, threatened with closure, will stay open under new ownership. This is partly possible because the cabinet is making a loan of € 6.7 million available. A principal agreement has been signed with the new owners, as State Secretary of Economic Affairs Mona Keijzer wrote in a letter to the Lower House on Thursday.

According to the government, preservation of the factory is important to better guarantee the availability of medicines in the Netherlands. The House of Representatives previously insisted on maintaining production capacity in the Netherlands. Certainly after the outbreak of the corona pandemic, there are fears that imports of medicines from countries outside Europe could be endangered.

Read more: https://fd.nl/ondernemen/1353437/kabinet-schiet-te-hulp-bij-doorstart-farmafabriek-apotex

Media contact

If you have any questions, please get in touch with us via info@innogenerics.com.

Over InnoGenerics

InnoGenerics is proud to be a major Dutch generic drug manufacturer doing everything we can to make patients stronger and better. We do this by offering high quality medicines and services to our customers: reliable, affordable and sustainable. Our values of Quality, Reliability, Sustainability and Innovation are our compass to achieve our goal.

Located at the Leiden Bio Science Park (LBSP) in the Netherlands, we formulate a range of important generic medicines in tablet form such as painkillers, sedatives, anti-epileptics, antidepressants and cholesterol-lowering drugs. Our office and factory location is within walking distance of the Leiden University Medical Center (LUMC) and surrounded by innovative, international pharmaceutical companies. From here we follow our goal of making important generic medicines available on a large scale and delivering them reliably to our customers. 

At the same time, we are inspired to invest, together with our partners, in innovative concepts to achieve (even) better solutions that make patients stronger and better. We do this because we believe that things can always be done better and because innovation and development is the key to becoming better as an organization. This is also necessary to be able to continue to reliably deliver better solutions to the patient. Together with 80 enthusiastic colleagues, it is our mission to do everything to make patients stronger and better. Now and in the future.

EN
Skip to content